07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

The therapeutic index, as determined by the rotarod test was within the range of the known anti<br />

epileptics. The onset of action was extremely fast showing its ability to quickly reach the brain.<br />

To explore possible use in psychiatric disorders, NW-3381 was evaluated in the<br />

amphetamine/chlordiazepoxide-induced hyperactivity test, a model of mania in which<br />

lamotrigine and other antiepileptics used in clinical practice <strong>for</strong> the treatment of bipolar disorders<br />

have been shown to be active. In this test NW-3381 was efficacious at relatively low doses of 5<br />

and 10mg/kg ip (bid) without affecting basal locomotion. Finally, the effects of NW-3381 and<br />

lamotrigine were tested in a pharmacological mouse model of cognitive dysfunctions in<br />

schizophrenia. Both lamotrigine (27 mg/kg ip) and NW-3381 (10mg/kg ip) were active in<br />

preventing the PCP-induced impairment in attentional per<strong>for</strong>mance in the 5-choice serial<br />

reaction task.<br />

Taking in account that NW-3381 has low potential <strong>for</strong> drug-drug interactions as well as low cell<br />

toxicity and fast onset of action, these in vivo data indicate NW-3381 as possible candidate <strong>for</strong><br />

epilepsy and psychiatric disorders therapy.<br />

Disclosures: E. Izzo, None; M. Calabresi, None; C. Sabido-David , None; S. Parini, None; A.<br />

Vezzani, None; M. Carli, None; S. Balosso, None; K. Wedzony, None; P. Salvati, None.<br />

Poster<br />

235. Ion Channels in Disease I<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 235.7/C53<br />

Topic: B.04.d. Ion channels and disease<br />

<strong>Title</strong>: Electrophysiological characterization of NW-3381, a potent sodium channel blocker<br />

active in animal models <strong>for</strong> epilepsy and psychiatric disorders<br />

Authors: L. FARAVELLI, E. COLOMBO, C. SABIDO-DAVID, *P. SALVATI;<br />

Newron Pharmaceuticals SpA, Bresso MI, Italy<br />

<strong>Abstract</strong>: Sodium channels are involved in the neuronal hyper-excitability that can occur in<br />

pathological conditions such as epilepsy, pain and psychiatric disorders.<br />

Compound NW-3381 was selected from Newron‟ ion channels program, <strong>for</strong> its high affinity <strong>for</strong><br />

sodium channels, good preliminary profile in terms of selectivity and developability and activity<br />

in animal models of epilepsy mania and schizophrenia.<br />

Patch clamp experiments in isolated rat cortical neurons showed that NW-3381 has a selective,<br />

sub-micromolar and voltage dependent inhibition of Na + currents with an apparent affinity <strong>for</strong><br />

inactivated channels Ki of 0.2µM. Furthermore, in the same neurons, the sustained repetitive<br />

firing is significantly reduced by NW-3381 in a concentration range of 3-10µM, ten times more

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!